Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies

Pharmacy World and Science

Volumn 30, Issue 3, 2008, Pages 222-226

  Botomino, Andrea ^a   Bruppacher, Rudolf ^b   Krähenbühl, Stephan ^a,c   Hersberger, Kurt E ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Body weight; Lifestyle change; Overweight; Pharmaceutical care; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COUNSELING; PHARMACEUTICAL CARE; PHYSICAL ACTIVITY; QUESTIONNAIRE; SCREENING; WEIGHT CHANGE;

BODY MASS INDEX; BODY WEIGHT; COUNSELING; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE SURVEYS; HUMANS; LIFE STYLE; MALE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHARMACIES; QUESTIONNAIRES; RISK; SWITZERLAND;

EID: 42249101402     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-007-9174-3     Document Type: Article

References (10)

1. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343-50.
2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393-403.
3. Hersberger KE, Botomino A, Mancini M, Bruppacher R. Sequential screening for diabetes-evaluation of a campaign in Swiss community pharmacies. Pharm World Sci 2006;28(3):171-9.
4. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot 1997;12(1):38-48.
5. James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM study group. Sibutramine trial of obesity reduction and maintenance. Lancet 2000;356(9248):2119-25.
6. Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998;352(9123):167-72.
7. Dzien A, Dzien-Bischinger C, Lechleitner M. Seasonal fluctuation in body mass index. Clin Nutr. 2003;22(4):425-6.
8. Visscher TL, Seidell JC. Time trends (1993-1997) and seasonal variation in body mass index and waist circumference in the Netherlands. Int J Obes Relat Metab Disord 2004.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-421.
10. Ahrens RA, Hower M, Best AM. Effects of weight reduction interventions by community pharmacists. J Am Pharm Assoc (Wash) 2003;43(5):583-9.